Medical devices, healthcare technology and the business of care
PMA approval · P230030

FARAPULSE Pulsed Field Ablation System (FARAWAVE Pulsed Field Ablation Catheter, FARASTAR Catheter Connection Cable,

Farapulse, Inc. · Decision date Jan 30, 2024

MEDTECHLEDGER EXPLANATIONP230030

What did the FDA approve?

The FDA approved the FARAPULSE Pulsed Field Ablation System on January 30, 2024. The approval covers the FARAWAVE Pulsed Field Ablation Catheter, FARASTAR Pulsed Field Ablation Generator, FARASTAR Recording System Module, FARASTAR Catheter Connection Cable, and associated cables. The catheter and generator are indicated for isolation of pulmonary veins in treating drug-refractory, recurrent, symptomatic paroxysmal atrial fibrillation.

The recording system module is indicated for use in an electrophysiology lab as a filtering/protection unit between the patient and attached recording or ECG systems, and as an interface for cardiac stimulation output. The connection cable is intended for use with a FARAPULSE catheter during an electrophysiology procedure for cardiac tissue ablation. The source statement reports intended use and indications; it does not independently establish safety or clinical effectiveness.

FDA approval order statement

approval for the FARAPULSE Pulsed Field Ablation System (FARAWAVE Pulsed Field Ablation Catheter, FARASTAR Catheter Connection Cable, FARASTAR Pulsed Field Ablation Generator, FARASTAR Recording System Module, FARASTAR Stimulation Module Cable, FARASTAR EGM Cable, FARASTAR Stimulation Module Male Cable, FARASTAR Stimulation Module Female Cable, FARASTAR Stimulation Module Female Cable, FARASTAR Stimulation Module Y-Cable Long, FARASTAR Stimulation Module Y-Cable Short, FARASTAR Recording System Module Catheter Pin Cable, FARASTAR Recording System Module ECG Trunk Cable (AAMI/IEC), FARASTAR Recording System Module ECG Output Cable (AAMI/IEC), FARASTAR Recording System Module EGM Input Module, FARASTAR SNAP CABLE R/L (AAMI/IEC), FARASTAR SNAP CABLE V SET (AAMI/IEC)). This device is indicated for:FARAWAVE Pulsed Field Ablation Catheter: The FARAWAVE Catheter is indicated for the isolation of pulmonary veins in the treatment of drug-refractory, recurrent, symptomatic Paroxysmal Atrial Fibrillation (PAF).FARASTAR Pulsed Field Ablation Generator: The FARASTAR PFA Generator when used in conjunction with the FARAWAVE PFA Catheter, is indicated for the isolation of pulmonary veins in the treatment of drug-refractory, recurrent, symptomatic Paroxysmal Atrial Fibrillation (PAF).FARASTAR Recording System Module: The FARASTAR Recording System Module (RSM) is indicated for use in an electrophysiology lab environment, as a filtering/protection unit to be connected between the patient and any attached recording systems and/or ECG systems, and as an interface for cardiac stimulation output. FARASTAR Catheter Connection Cable: The FARASTAR Connection Cable is intended to be used with a FARAPULSE Catheter during an Electrophysiology procedure for cardiac tissue ablation
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
Jan 30, 2024

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P230030
Regulatory pathway
Premarket approval application
Product code
QZI
Decision code
APPR
Decision date
Jan 30, 2024
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible Electroporation.

Product code
QZI
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P230030 received

    Application receipt date recorded by FDA.

  2. P230030 · FDA decision

    APPR

  3. P230030/S024 · Related supplement

    FARASTAR Pulsed Field Ablation (PFA) Generator; FARASTAR Mapping System Module (MSM); FARASTAR Recording System Modul

  4. P230030/S025 · Related supplement

    FARAPULSE Pulsed Field Ablation System (FARAWAVE Pulsed Field Ablation Catheter, FARASTAR Catheter Connection Cable,

Timeline entries are records held by MedtechLedger for P230030. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P230030

Explore the linked device profile

Other records with product code QZI

Product / regulatory recordCompanyPathwayDecision dateSource
Biosense Webster, Inc.PMA supplementNov 3, 2026FDA
Kardium, Inc.PMA supplementOct 27, 2026FDA
Kardium, Inc.PMA supplementOct 23, 2026FDA
Volt PFA SystemP250022/S002
ABBOTT MEDICALPMA supplementOct 15, 2026FDA
Medtronic, Inc.PMA supplementOct 9, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Farapulse, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
3715 Haven Ave., Suite 110, Menlo Park, CA, 94025

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records